Associate Professor Woojin Kim

Principal Research Fellow
Central Clinical School

Member of the Brain and Mind Centre


Map

Current research students

Project title Research student
Investigating the pathomechanism of frontotemporal dementia Jared KATZEFF

Selected grants

2018

  • Lipidomics analysis using serum and CSF from LRRK2-associated Parkinson´┐Żs disease patients; Dzamko N, Kim W; Michael J Fox Foundation for Parkinsons Research/Research Support.

2017

  • Scott Kim group research funds (Lipids and neurodegenerative diseases); Kim W; Neuroscience Research Australia/Research Support.
  • COQ2 mutation and methylation dysfunction leading to a-synuclein pathology; Kim W, Halliday G; Multiple System Atrophy Coalition/Seed Grant.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Kim, W., Fu, Y., Dobson-Stone, C., Hsiao, J., Shang, K., Hallupp, M., Schofield, P., Garner, B., Karl, T., Kwok, J. (2018). Effect of Fluvoxamine on Amyloid-beta Peptide Generation and Memory. Journal of Alzheimer's Disease, 62(4), 1777-1787. [More Information]
  • Ahmed, R., Highton-Williamson, E., Caga, J., Thornton, N., Ramsey, E., Zoing, M., Kim, W., Halliday, G., Piguet, O., Hodges, J., Kiernan, M., et al (2018). Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition. Journal of Alzheimer's Disease, 61(2), 773-783. [More Information]
  • Kim, W., Jary, E., Pickford, R., He, Y., Ahmed, R., Piguet, O., Hodges, J., Halliday, G. (2018). Lipidomics analysis of Behavioral Variant Frontotemporal Dementia: a scope for Biomarker Development. Frontiers in Neurology, 9, 104. [More Information]
  • Atashrazm, F., Hammond, D., Perera, G., Dobson-Stone, C., Mueller, N., Pickford, R., Kim, W., Kwok, J., Lewis, S., Halliday, G., Dzamko, N. (2018). Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease. Scientific Reports, 8(1), 15446. [More Information]
  • Forrest, S., Kril, J., Stevens, C., Kwok, J., Hallupp, M., Kim, W., Huang, Y., McGinley, C., Werka, H., Kiernan, M., Hodges, J., Halliday, G., et al (2018). Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Brain, 141(2), 521-534. [More Information]
  • Hsiao, J., Halliday, G., Kim, W. (2017). (alpha)-Synuclein regulates neuronal cholesterol efflux. Molecules, 22(10), 1-8. [More Information]
  • Bhatia, S., Fu, Y., Hsiao, J., Halliday, G., Kim, W. (2017). Deletion of Alzheimer's Disease Risk Gene ABCA7 Alters White Adipose Tissue Development and Leptin Levels. Journal of Alzheimer's Disease Reports, 1, 237-247. [More Information]
  • Tan, R., Yang, Y., Kim, W., Dobson-Stone, C., Kwok, J., Kiernan, M., Halliday, G. (2017). Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis. Acta Neuropathologica Communications, 5(76), 1-7. [More Information]
  • Van Langenhove, T., Piquet, O., Burrell, J., Leyton, C., Foxe, D., Abela, M., Bartley, L., Kim, W., Jary, E., Huang, Y., Hodges, J., et al (2017). Predicting development of amyotrophic lateral sclerosis in frontotemporal dementia. Journal of Alzheimer's Disease, 58(1), 163-170. [More Information]
  • Fu, Y., Hsiao, J., Paxinos, G., Halliday, G., Kim, W. (2016). ABCA7 Mediates Phagocytic Clearance of Amyloid-(beta) in the Brain. Journal of Alzheimer's Disease, 54(2), 569-584. [More Information]
  • Bleasel, J., Halliday, G., Kim, W. (2016). Animal modeling an oligodendrogliopathy - multiple system atrophy. Acta Neuropathologica Communications, 4(1), 1-15. [More Information]
  • Coupland, K., Kim, W., Halliday, G., Hallupp, M., Dobson-Stone, C., Kwok, J. (2016). Role of the long non-coding RNA MAPT-AS1 in regulation of microtubule associated protein tau (MAPT) expression in Parkinson's disease. PloS One, 11(6), 1-14. [More Information]
  • Fu, Y., Hsiao, J., Paxinos, G., Halliday, G., Kim, W. (2015). ABCA5 Regulates amyloid-beta peptide production and is associated with Alzheimer's disease neuropathology. Journal of Alzheimer's Disease, 43(3), 857-869. [More Information]
  • Rusznak, Z., Kim, W., Hsiao, J., Halliday, G., Paxinos, G., Fu, Y. (2015). Early in vivo effects of the human mutant amyloid-? protein precursor (hA?PPSwInd) on the mouse olfactory bulb. Journal of Alzheimer's Disease, 49(2), 443-457. [More Information]
  • Coupland, K., Kim, W., Halliday, G., Hallupp, M., Dobson-Stone, C., Kwok, J. (2015). Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease. Current Alzheimer Research, 12(8), 745-751. [More Information]
  • Mills, J., Kavanagh, T., Kim, W., Chen, B., Waters, P., Halliday, G., Janitz, M. (2015). High expression of long intervening non-coding RNA OLMALINC in the human cortical white matter is associated with regulation of oligodendrocyte maturation. Molecular Brain, 8(1), 1-12. [More Information]
  • Mills, J., Chen, J., Kim, W., Waters, P., Prabowo, A., Aronica, E., Halliday, G., Janitz, M. (2015). Long intervening non-coding RNA 00320 is human brain-specific and highly expressed in the cortical white matter. Neurogenetics, 16(3), 201-213. [More Information]
  • Mills, J., Kim, W., Halliday, G., Janitz, M. (2015). Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy. Neurogenetics, 16(2), 107-122. [More Information]
  • Fu, Y., Rusznak, Z., Kwok, J., Kim, W., Paxinos, G. (2014). Age-Dependent Alterations of the Hippocampal Cell Composition and Proliferative Potential in the hA-Beta-PPSwInd-J20 Mouse. Journal of Alzheimer's Disease, 41(4), 1177-1192. [More Information]
  • Kim, W., Kagedal, K., Halliday, G. (2014). Alpha-synuclein biology in Lewy body diseases. Alzheimers Research & Therapy, 6(1), 1-9. [More Information]
  • Don, A., Hsiao, J., Bleasel, J., Couttas, T., Halliday, G., Kim, W. (2014). Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy. Acta Neuropathologica Communications, 2(1), 1-14. [More Information]
  • Coupland, K., Mellick, G., Silburn, P., Mather, K., Armstrong, N., Sachdev, P., Brodaty, H., Huang, Y., Halliday, G., Hallupp, M., et al (2014). DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro. Movement Disorders, 29(13), 1606-1614. [More Information]
  • Wong, J., Halliday, G., Kim, W. (2014). Exploring myelin dysfunction in multiple system atrophy. Experimental Neurobiology, 23(4), 337-344. [More Information]
  • Bleasel, J., Wong, J., Halliday, G., Kim, W. (2014). Lipid dysfunction and pathogenesis of multiple system atrophy. Acta Neuropathologica Communications, 2(1), 1-11. [More Information]
  • Murphy, K., Gysbers, A., Abbott, S., Tayebi, N., Kim, W., Sidransky, E., Cooper, A., Garner, B., Halliday, G. (2014). Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease. Brain, 137(3), 834-848. [More Information]
  • Kim, W., Hsiao, J., Bhatia, S., Glaros, E., Don, A., Tsuruoka, S., Weickert, C., Halliday, G. (2013). ABCA8 stimulates sphingomyelin production in oligodendrocytes. Biochemical Journal, 452(3), 401-410. [More Information]
  • Kim, W., Li, H., Ruberu, K., Chan, S., Elliott, D., Low, J., Cheng, D., Karl, T., Garner, B. (2013). Deletion of Abca7 Increases Cerebral Amyloid-Beta Accumulation in the J20 Mouse Model of Alzheimer's Disease. Journal of Neuroscience, 33(10), 4387-4394. [More Information]
  • Hsiao, J., Fu, Y., Hill, A., Halliday, G., Kim, W. (2013). Elevation in Sphingomyelin Synthase Activity Is Associated with Increases in Amyloid-Beta Peptide Generation. PloS One, 8(8), 1-10. [More Information]
  • Dang, T., Dobson-Stone, C., Glaros, E., Kim, W., Hallupp, M., Bartley, L., Piguet, O., Hodges, J., Halliday, G., Double, K., et al (2013). Endogenous progesterone levels and frontotemporal dementia: Modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model. Disease Models and Mechanisms, 6(5), 1198-1204. [More Information]
  • Bleasel, J., Hsiao, J., Halliday, G., Kim, W. (2013). Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins. Journal of Parkinson's Disease, 3(3), 331-339. [More Information]
  • Kavanagh, T., Mills, J., Kim, W., Halliday, G., Janitz, M. (2013). Pathway analysis of the human brain transcriptome in disease. Journal of Molecular Neuroscience, 51(1), 28-36. [More Information]
  • Mills, J., Kavanagh, T., Kim, W., Chen, B., Kawahara, Y., Halliday, G., Janitz, M. (2013). Unique Transcriptome Patterns of the White and Grey Matter Corroborate Structural and Functional Heterogeneity in the Human Frontal Lobe. PloS One, 8(10), 1-18. [More Information]
  • Kim, W., Halliday, G. (2012). Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression. Journal of Parkinson's Disease, 2(1), 41-46. [More Information]
  • Karl, T., Bhatia, S., Cheng, D., Kim, W., Garner, B. (2012). Cognitive phenotyping of amyloid precursor protein transgenic J20 mice. Behavioural Brain Research, 228(2), 392-397. [More Information]
  • Elliott, D., Kim, W., Gorrisen, S., Halliday, G., Kwok, J. (2012). Leucine-Rich Repeat Kinase 2 and Alternative Splicing in Parkinson's Disease. Movement Disorders, 27(8), 1004-1011. [More Information]
  • Logge, W., Cheng, D., Chesworth, R., Bhatia, S., Garner, B., Kim, W., Karl, T. (2012). Role of Abca7 in Mouse Behaviours Relevant to Neurodegenerative Diseases. PloS One, 7(9), 1-9. [More Information]
  • Bhatia, S., Knoch, B., Wong, J., Kim, W., Else, P., Oakley, A., Garner, B. (2012). Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: Implications for lipid antioxidant activity and Alzheimer's disease. Biochemical Journal, 442(3), 713-721. [More Information]
  • Elliott, D., Tsoi, K., Holinkova, S., Chan, S., Kim, W., Halliday, G., Rye, K., Garner, B. (2011). Isoform-specific proteolysis of apolipoprotein-E in the brain. Neurobiology of Aging, 32(2), 257-271. [More Information]
  • Cheng, D., Jenner, A., Shui, G., Cheong, W., Mitchell, T., Nealon, J., Kim, W., McCann, H., Wenk, M., Halliday, G., et al (2011). Lipid pathway alterations in parkinson's disease primary visual cortex. PloS One, 6(2), 1-17. [More Information]
  • Kim, W., Hill, A., Fitzgerald, M., Freeman, M., Evin, G., Garner, B. (2011). Wild Type and Tangier Disease ABCA1 Mutants Modulate Cellular Amyloid-Beta Production Independent of Cholesterol Efflux Activity. Journal of Alzheimer's Disease, 27(2), 441-452. [More Information]
  • Li, H., Kim, W., Guillemin, G., Hill, A., Evin, G., Garner, B. (2010). Modulation of amyloid precursor protein processing by synthetic ceramide analogues. Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, 1801 (8), 887-895. [More Information]
  • Kim, W., Chan, S., Hill, A., Guillemin, G., Garner, B. (2009). Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons. Journal of Alzheimer's Disease, 16(1), 121-131. [More Information]
  • Kim, W., Elliott, D., Kockx, M., Kritharides, L., Rye, K., Jans, D., Garner, B. (2008). Analysis of apolipoprotein E nuclear localization using green fluorescent protein and biotinylation approaches. Biochemical Journal, 409(3), 701-709. [More Information]
  • Chan, S., Kim, W., Kwok, J., Hill, A., Cappai, R., Rye, K., Garner, B. (2008). ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro. Journal of Neurochemistry, 106(2), 793-804. [More Information]
  • Glaros, E., Kim, W., Quinn, C., Jessup, W., Rye, K., Garner, B. (2008). Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice. Journal of Lipid Research, 49(2), 324-331. [More Information]
  • Glaros, E., Kim, W., Rye, K., Shayman, J., Garner, B. (2008). Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice. Journal of Lipid Research, 49(8), 1677-1681. [More Information]
  • Glaros, E., Kim, W., Wu, B., Suarna, C., Quinn, C., Rye, K., Stocker, R., Jessup, W., Garner, B. (2007). Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration. Biochemical Pharmacology, 73(9), 1340-1346. [More Information]
  • Kim, W., Rahmanto, A., Kamili, A., Rye, K., Guillemin, G., Gelissen, I., Jessup, W., Hill, A., Garner, B. (2007). Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid- Peptide Generation. Journal of Biological Chemistry, 282, 2851-2861.
  • Kim, W., Guillemin, G., Glaros, E., Lim, C., Garner, B. (2006). Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells. NeuroReport, 17(9), 891-896. [More Information]
  • Kim, W., Rahmanto, A., Kamili, A., Rye, K., Guillemin, G., Gelissen, I., Jessup, W., Hill, A., Garner, B. (2006). Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein-E discs and suppression of amyloid-beta peptide generation. Journal of Biological Chemistry, 282(5), 2851-2861. [More Information]
  • Glaros, E., Kim, W., Quinn, C., Wong, J., Gelissen, I., Jessup, W., Garner, B. (2005). Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator. Journal of Biological Chemistry, 280, 24515-24523.

2018

  • Kim, W., Fu, Y., Dobson-Stone, C., Hsiao, J., Shang, K., Hallupp, M., Schofield, P., Garner, B., Karl, T., Kwok, J. (2018). Effect of Fluvoxamine on Amyloid-beta Peptide Generation and Memory. Journal of Alzheimer's Disease, 62(4), 1777-1787. [More Information]
  • Ahmed, R., Highton-Williamson, E., Caga, J., Thornton, N., Ramsey, E., Zoing, M., Kim, W., Halliday, G., Piguet, O., Hodges, J., Kiernan, M., et al (2018). Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition. Journal of Alzheimer's Disease, 61(2), 773-783. [More Information]
  • Kim, W., Jary, E., Pickford, R., He, Y., Ahmed, R., Piguet, O., Hodges, J., Halliday, G. (2018). Lipidomics analysis of Behavioral Variant Frontotemporal Dementia: a scope for Biomarker Development. Frontiers in Neurology, 9, 104. [More Information]
  • Atashrazm, F., Hammond, D., Perera, G., Dobson-Stone, C., Mueller, N., Pickford, R., Kim, W., Kwok, J., Lewis, S., Halliday, G., Dzamko, N. (2018). Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease. Scientific Reports, 8(1), 15446. [More Information]
  • Forrest, S., Kril, J., Stevens, C., Kwok, J., Hallupp, M., Kim, W., Huang, Y., McGinley, C., Werka, H., Kiernan, M., Hodges, J., Halliday, G., et al (2018). Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Brain, 141(2), 521-534. [More Information]

2017

  • Hsiao, J., Halliday, G., Kim, W. (2017). (alpha)-Synuclein regulates neuronal cholesterol efflux. Molecules, 22(10), 1-8. [More Information]
  • Bhatia, S., Fu, Y., Hsiao, J., Halliday, G., Kim, W. (2017). Deletion of Alzheimer's Disease Risk Gene ABCA7 Alters White Adipose Tissue Development and Leptin Levels. Journal of Alzheimer's Disease Reports, 1, 237-247. [More Information]
  • Tan, R., Yang, Y., Kim, W., Dobson-Stone, C., Kwok, J., Kiernan, M., Halliday, G. (2017). Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis. Acta Neuropathologica Communications, 5(76), 1-7. [More Information]
  • Van Langenhove, T., Piquet, O., Burrell, J., Leyton, C., Foxe, D., Abela, M., Bartley, L., Kim, W., Jary, E., Huang, Y., Hodges, J., et al (2017). Predicting development of amyotrophic lateral sclerosis in frontotemporal dementia. Journal of Alzheimer's Disease, 58(1), 163-170. [More Information]

2016

  • Fu, Y., Hsiao, J., Paxinos, G., Halliday, G., Kim, W. (2016). ABCA7 Mediates Phagocytic Clearance of Amyloid-(beta) in the Brain. Journal of Alzheimer's Disease, 54(2), 569-584. [More Information]
  • Bleasel, J., Halliday, G., Kim, W. (2016). Animal modeling an oligodendrogliopathy - multiple system atrophy. Acta Neuropathologica Communications, 4(1), 1-15. [More Information]
  • Coupland, K., Kim, W., Halliday, G., Hallupp, M., Dobson-Stone, C., Kwok, J. (2016). Role of the long non-coding RNA MAPT-AS1 in regulation of microtubule associated protein tau (MAPT) expression in Parkinson's disease. PloS One, 11(6), 1-14. [More Information]

2015

  • Fu, Y., Hsiao, J., Paxinos, G., Halliday, G., Kim, W. (2015). ABCA5 Regulates amyloid-beta peptide production and is associated with Alzheimer's disease neuropathology. Journal of Alzheimer's Disease, 43(3), 857-869. [More Information]
  • Rusznak, Z., Kim, W., Hsiao, J., Halliday, G., Paxinos, G., Fu, Y. (2015). Early in vivo effects of the human mutant amyloid-? protein precursor (hA?PPSwInd) on the mouse olfactory bulb. Journal of Alzheimer's Disease, 49(2), 443-457. [More Information]
  • Coupland, K., Kim, W., Halliday, G., Hallupp, M., Dobson-Stone, C., Kwok, J. (2015). Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease. Current Alzheimer Research, 12(8), 745-751. [More Information]
  • Mills, J., Kavanagh, T., Kim, W., Chen, B., Waters, P., Halliday, G., Janitz, M. (2015). High expression of long intervening non-coding RNA OLMALINC in the human cortical white matter is associated with regulation of oligodendrocyte maturation. Molecular Brain, 8(1), 1-12. [More Information]
  • Mills, J., Chen, J., Kim, W., Waters, P., Prabowo, A., Aronica, E., Halliday, G., Janitz, M. (2015). Long intervening non-coding RNA 00320 is human brain-specific and highly expressed in the cortical white matter. Neurogenetics, 16(3), 201-213. [More Information]
  • Mills, J., Kim, W., Halliday, G., Janitz, M. (2015). Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy. Neurogenetics, 16(2), 107-122. [More Information]

2014

  • Fu, Y., Rusznak, Z., Kwok, J., Kim, W., Paxinos, G. (2014). Age-Dependent Alterations of the Hippocampal Cell Composition and Proliferative Potential in the hA-Beta-PPSwInd-J20 Mouse. Journal of Alzheimer's Disease, 41(4), 1177-1192. [More Information]
  • Kim, W., Kagedal, K., Halliday, G. (2014). Alpha-synuclein biology in Lewy body diseases. Alzheimers Research & Therapy, 6(1), 1-9. [More Information]
  • Don, A., Hsiao, J., Bleasel, J., Couttas, T., Halliday, G., Kim, W. (2014). Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy. Acta Neuropathologica Communications, 2(1), 1-14. [More Information]
  • Coupland, K., Mellick, G., Silburn, P., Mather, K., Armstrong, N., Sachdev, P., Brodaty, H., Huang, Y., Halliday, G., Hallupp, M., et al (2014). DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro. Movement Disorders, 29(13), 1606-1614. [More Information]
  • Wong, J., Halliday, G., Kim, W. (2014). Exploring myelin dysfunction in multiple system atrophy. Experimental Neurobiology, 23(4), 337-344. [More Information]
  • Bleasel, J., Wong, J., Halliday, G., Kim, W. (2014). Lipid dysfunction and pathogenesis of multiple system atrophy. Acta Neuropathologica Communications, 2(1), 1-11. [More Information]
  • Murphy, K., Gysbers, A., Abbott, S., Tayebi, N., Kim, W., Sidransky, E., Cooper, A., Garner, B., Halliday, G. (2014). Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease. Brain, 137(3), 834-848. [More Information]

2013

  • Kim, W., Hsiao, J., Bhatia, S., Glaros, E., Don, A., Tsuruoka, S., Weickert, C., Halliday, G. (2013). ABCA8 stimulates sphingomyelin production in oligodendrocytes. Biochemical Journal, 452(3), 401-410. [More Information]
  • Kim, W., Li, H., Ruberu, K., Chan, S., Elliott, D., Low, J., Cheng, D., Karl, T., Garner, B. (2013). Deletion of Abca7 Increases Cerebral Amyloid-Beta Accumulation in the J20 Mouse Model of Alzheimer's Disease. Journal of Neuroscience, 33(10), 4387-4394. [More Information]
  • Hsiao, J., Fu, Y., Hill, A., Halliday, G., Kim, W. (2013). Elevation in Sphingomyelin Synthase Activity Is Associated with Increases in Amyloid-Beta Peptide Generation. PloS One, 8(8), 1-10. [More Information]
  • Dang, T., Dobson-Stone, C., Glaros, E., Kim, W., Hallupp, M., Bartley, L., Piguet, O., Hodges, J., Halliday, G., Double, K., et al (2013). Endogenous progesterone levels and frontotemporal dementia: Modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model. Disease Models and Mechanisms, 6(5), 1198-1204. [More Information]
  • Bleasel, J., Hsiao, J., Halliday, G., Kim, W. (2013). Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins. Journal of Parkinson's Disease, 3(3), 331-339. [More Information]
  • Kavanagh, T., Mills, J., Kim, W., Halliday, G., Janitz, M. (2013). Pathway analysis of the human brain transcriptome in disease. Journal of Molecular Neuroscience, 51(1), 28-36. [More Information]
  • Mills, J., Kavanagh, T., Kim, W., Chen, B., Kawahara, Y., Halliday, G., Janitz, M. (2013). Unique Transcriptome Patterns of the White and Grey Matter Corroborate Structural and Functional Heterogeneity in the Human Frontal Lobe. PloS One, 8(10), 1-18. [More Information]

2012

  • Kim, W., Halliday, G. (2012). Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression. Journal of Parkinson's Disease, 2(1), 41-46. [More Information]
  • Karl, T., Bhatia, S., Cheng, D., Kim, W., Garner, B. (2012). Cognitive phenotyping of amyloid precursor protein transgenic J20 mice. Behavioural Brain Research, 228(2), 392-397. [More Information]
  • Elliott, D., Kim, W., Gorrisen, S., Halliday, G., Kwok, J. (2012). Leucine-Rich Repeat Kinase 2 and Alternative Splicing in Parkinson's Disease. Movement Disorders, 27(8), 1004-1011. [More Information]
  • Logge, W., Cheng, D., Chesworth, R., Bhatia, S., Garner, B., Kim, W., Karl, T. (2012). Role of Abca7 in Mouse Behaviours Relevant to Neurodegenerative Diseases. PloS One, 7(9), 1-9. [More Information]
  • Bhatia, S., Knoch, B., Wong, J., Kim, W., Else, P., Oakley, A., Garner, B. (2012). Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: Implications for lipid antioxidant activity and Alzheimer's disease. Biochemical Journal, 442(3), 713-721. [More Information]

2011

  • Elliott, D., Tsoi, K., Holinkova, S., Chan, S., Kim, W., Halliday, G., Rye, K., Garner, B. (2011). Isoform-specific proteolysis of apolipoprotein-E in the brain. Neurobiology of Aging, 32(2), 257-271. [More Information]
  • Cheng, D., Jenner, A., Shui, G., Cheong, W., Mitchell, T., Nealon, J., Kim, W., McCann, H., Wenk, M., Halliday, G., et al (2011). Lipid pathway alterations in parkinson's disease primary visual cortex. PloS One, 6(2), 1-17. [More Information]
  • Kim, W., Hill, A., Fitzgerald, M., Freeman, M., Evin, G., Garner, B. (2011). Wild Type and Tangier Disease ABCA1 Mutants Modulate Cellular Amyloid-Beta Production Independent of Cholesterol Efflux Activity. Journal of Alzheimer's Disease, 27(2), 441-452. [More Information]

2010

  • Li, H., Kim, W., Guillemin, G., Hill, A., Evin, G., Garner, B. (2010). Modulation of amyloid precursor protein processing by synthetic ceramide analogues. Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, 1801 (8), 887-895. [More Information]

2009

  • Kim, W., Chan, S., Hill, A., Guillemin, G., Garner, B. (2009). Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons. Journal of Alzheimer's Disease, 16(1), 121-131. [More Information]

2008

  • Kim, W., Elliott, D., Kockx, M., Kritharides, L., Rye, K., Jans, D., Garner, B. (2008). Analysis of apolipoprotein E nuclear localization using green fluorescent protein and biotinylation approaches. Biochemical Journal, 409(3), 701-709. [More Information]
  • Chan, S., Kim, W., Kwok, J., Hill, A., Cappai, R., Rye, K., Garner, B. (2008). ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro. Journal of Neurochemistry, 106(2), 793-804. [More Information]
  • Glaros, E., Kim, W., Quinn, C., Jessup, W., Rye, K., Garner, B. (2008). Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice. Journal of Lipid Research, 49(2), 324-331. [More Information]
  • Glaros, E., Kim, W., Rye, K., Shayman, J., Garner, B. (2008). Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice. Journal of Lipid Research, 49(8), 1677-1681. [More Information]

2007

  • Glaros, E., Kim, W., Wu, B., Suarna, C., Quinn, C., Rye, K., Stocker, R., Jessup, W., Garner, B. (2007). Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration. Biochemical Pharmacology, 73(9), 1340-1346. [More Information]
  • Kim, W., Rahmanto, A., Kamili, A., Rye, K., Guillemin, G., Gelissen, I., Jessup, W., Hill, A., Garner, B. (2007). Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid- Peptide Generation. Journal of Biological Chemistry, 282, 2851-2861.

2006

  • Kim, W., Guillemin, G., Glaros, E., Lim, C., Garner, B. (2006). Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells. NeuroReport, 17(9), 891-896. [More Information]
  • Kim, W., Rahmanto, A., Kamili, A., Rye, K., Guillemin, G., Gelissen, I., Jessup, W., Hill, A., Garner, B. (2006). Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein-E discs and suppression of amyloid-beta peptide generation. Journal of Biological Chemistry, 282(5), 2851-2861. [More Information]

2005

  • Glaros, E., Kim, W., Quinn, C., Wong, J., Gelissen, I., Jessup, W., Garner, B. (2005). Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator. Journal of Biological Chemistry, 280, 24515-24523.

To update your profile click here. For support on your academic profile contact .